LL-37 FK-13 |
| カタログ番号GA23144 |
FK-13は、LL-37のコアシーケンスであり、アクチンによって細菌プロテオリシスから保護されています。 FK-13はHIV-1に対して活性を示し、EC?? 3.4μMです。 N末端フェニルアラニンの除去が不活化を引き起こすため、FKRIVQRIKDFLRは人間のLL-37の最小抗HIV領域に相当します。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 717919-68-1
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
FK-13, core sequence of LL-37, is protected from bacterial proteolysis by actin. FK-13 showed activity against HIV-1, EC 3.4 μM. As removal of the N-terminal phenylalanine leads to inactivation, FKRIVQRIKDFLR corresponds to the minimal anti-HIV re
Average Rating: 5 (Based on Reviews and 4 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *